Do I need to provide Usual and Customary (U&C) generic pricing to Medicare beneficiaries at the point of sale?
Under section 1860D-4(k)(1) of the MMA, Part D sponsors will be required to ensure that pharmacies inform enrollees of any price differential between the brand name price and the lowest-priced generic version of a covered Part D drug available at that pharmacy. It is the plan’s responsibility to verify that community pharmacies are complying with this requirement. Bottom line: When you fill a Medicare prescription that has a generic equivalent, you must indicate the price differential between the price of that brand name drug and the price of the lowest-priced generic version of that drug available at your pharmacy.
